Product Search |
|
| Input Product Name Or Cas No. |
Category |
Products |
2-(2-hydroxyethyl)nicotinic acid hydroch |
2-(2-Hydroxyethyl)-3-pyridinecarboxylic |
3-Bromo-2-[2-(phenylmethoxy)ethyl]pyridi |
2-[2-(Phenylmethoxy)ethyl]-3-pyridinecar |
Phenylmethyl 2-[2-[[(1,1-dimethylethyl)d |
Phenylmethyl 2-(2-hydroxyethyl)-3-pyridi |
benzyl 2-(2-(benzoyloxy)ethyl)nicotinate |
Phenylmethyl 2-[2-(acetyloxy)ethyl]-3-py |
2-[2-(Acetyloxy)ethyl]-3-pyridinecarboxy |
2-[2-[[(1,1-Dimethylethyl)diphenylsilyl] |
1,3-Dioxane, 2-(2-bromo-6-fluorophenyl)- |
2-[2-[[(1,1-Dimethylethyl)diphenylsilyl] |
7,8-Dihydro-5H-pyrano[4,3-b]pyridin-5-on |
Benzene, 1-bromo-2-(dimethoxymethyl)-3-f |
2,2-Dimethyl-5-(phenylmethoxy)-4H-1,3-be |
2-(2-(benzoyloxy)ethyl)nicotinic acid |
1-Propanone, 1-[1,1′-biphenyl]-4-yl-2- |
4-Fluoro-2,3-dihydro-7-(methylsulfonyl)- |
3-(Difluoromethyl)-5-fluoro-1-methyl-1H- |
2-Methyl-1-[2-[5-(4-methylphenyl)-1H-imi |
Imidazo[1,2-c]pyrimidin-5(6H)-one, 8-bro |
8-Chloro-3,4-dihydro-7-(1-methylethoxy)- |
Ethyl 2-chloro-6-methyl-5-nitro-3-pyridi |
6-Methoxy-4-methyl-1H-pyrrolo[3,2-c]pyri |
7-Bromo-6-methoxy-4-methylthieno[3,2-c]p |
6-Methoxy-4-methylthieno[3,2-c]pyridine- |
4-Bromo-5-methoxy-7-methylthieno[2,3-c]p |
5-Methoxy-7-methylthieno[2,3-c]pyridine- |
2,4-Dimethyl-6-(phenylmethoxy)furo[3,2-c |
2,4-Dimethyl-6-(phenylmethoxy)furo[3,2-c |
7-Methyl-5-(phenylmethoxy)thieno[2,3-c]p |
1,1-Dimethylethyl 3-[(methoxyamino)carbo |
5,8-Dichloro-3,4-dihydro-7-(methoxy-3-ox |
N,N′-Bis[3-[[(4-methylphenyl)sulfonyl] |
1,3,5-tri(prop-2-yn-1-yl)-1,3,5-triazina |
5-(3,5-Dimethylphenyl)-3,4-dihydro-2H-py |
1-(3-Buten-1-yloxy)-2-methoxy-4-(2-prope |
1-Methyl-4-[(4-methyl-3-penten-1-yl)oxy] |
4-(3-Buten-1-yloxy)-3-ethoxybenzaldehyde |
3-Ethoxy-4-[(3-methyl-3-buten-1-yl)oxy]b |
1-Ethyl-4-[(4-methyl-3-penten-1-yl)oxy]b |
Benzaldehyde, 4-(3-cyclopenten-1-yloxy)- |
3-Ethoxy-4-(4-penten-1-yloxy)benzaldehyd |
3-Ethoxy-4-(3-penten-1-yloxy)benzaldehyd |
4-[[4-[(1-Oxo-2-propen-1-yl)oxy]phenoxy] |
4,4’-sulfonylbis((4-vinylphenoxy)benze |
(4-iodophenyl)bis(4-(trifluoromethyl)phe |
4-(Chlorosulfonyl)phenyl 2-propenoate |
1-Benzoylbenzotriazole |
2,2′-[Sulfonylbis(4,1-phenyleneoxy)]bi |
|
Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| W736725 | 3,4-dihydro-3-isopropylquinoxaline-2-carbonitrile | 63536-41-4 | 95% |
| W736726 | 3-phenyl-2-Quinoxalinecarbonitrile | 59393-45-2 | 95% |
| W736727 | 2,5-Furandicarbonitrile | 58491-62-6 | 95% |
| W736728 | 3-Isoquinolineacetonitrile | 58130-44-2 | 95% |
| W736729 | 2-ethoxyQuinoxaline | 57315-47-6 | 95% |
| W736730 | 3,5-diaminoBenzamide | 53882-15-8 | 95% |
| W736731 | 2-phenoxyQuinoxaline | 52598-53-5 | 95% |
| W736732 | 6-Phenanthridineacetonitrile | 51902-25-1 | 95% |
| W736733 | 5-Thiazoleacetonitrile | 50382-34-8 | 95% |
| W736734 | 2,6-Pyridinediacetonitrile | 46133-38-4 | 95% |
| W736735 | 2,5-Furandiacetonitrile | 41737-88-6 | 95% |
| W736736 | 1-methyl-1H-Imidazole-4-acetonitrile | 41065-00-3 | 95% |
| W736737 | 2-methoxyQuinoxaline | 39209-88-6 | 95% |
| W736738 | 2,3-Thiophenediacetonitrile | 38447-33-5 | 95% |
| W736739 | 2,5-Pyrimidinedicarbonitrile | 38275-58-0 | 95% |
| W736740 | 4-Quinazolinecarbonitrile | 36082-71-0 | 95% |
| W736741 | 9-Anthracenecarboxamide | 34810-13-4 | 95% |
| W736742 | 2-(1-piperidinyl)Quinoxaline | 34548-26-0 | 95% |
| W736743 | 2-(4-morpholinyl)Quinoxaline | 34548-25-9 | 95% |
| W736744 | 1-methyl-1H-Pyrrole-2,5-diacetonitrile | 34296-02-1 | 95% |
| W736745 | 2-benzylquinoxaline | 31102-97-3 | 95% |
| W736746 | 2-ethylQuinoxaline | 29750-44-5 | 95% |
| W736747 | 1-Isoquinolineacetonitrile | 27295-99-4 | 95% |
| W736748 | 2-(2-quinoxalinyl)Cyclohexanone | 19836-17-0 | 95% |
| W736749 | 1-phenyl-2-(2-quinoxalinyl)-1-Propanone | 19836-11-4 | 95% |
| W736750 | 2,4-Thiophenedicarbonitrile | 18853-41-3 | 95% |
| W736751 | 2,5-Thiophenedicarbonitrile | 18853-40-2 | 95% |
| W736752 | 3-methyl-2-Quinoxalinecarboxamide | 17357-92-5 | 95% |
| W736753 | 3-ethyl-2-Quinoxalinecarbonitrile | 17357-89-0 | 95% |
| W736754 | 3-methyl-2-Quinoxalinecarbonitrile | 17357-88-9 | 95% |
|
|
|
|